Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fabrizi, F.
Right arrow Articles by Locatelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fabrizi, F.
Right arrow Articles by Locatelli, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 8 1991-1997, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal

F Fabrizi, C Pozzi, M Farina, P Dattolo, G Lunghi, S Badalamenti, A Pagano and F Locatelli
Nephrology and Dialysis Units of Lecco, Lodi, Florence, and Milan Hospitals, Italy; The Institute of Hygiene and Preventive Medicine, University of Milan, Milan, Italy; Correspondence to: F Fabrizi, Division of Nephrology and Dialysis, Lecco Hospital, Via Ghislanzoni 22, I-22053 Lecco, Italy

Background. The relationship between hepatitis C virus (HCV) infection and acute or chronic glomerulonephritis (GN) is not well understood. Methods. Two hundred and eighty-four patients with biopsy-proven GN and other renal diseases were studied in a multicentre survey performed during the period 1992-1995. Several clinical parameters were collected for each patient at the time of renal biopsy. We made a multivariate analysis by logistic regression model to evaluate the independent association of clinical and histological patient characteristics with HCV infection, as detected by anti-HCV antibody testing. In addition, three patients with HCV-related liver disease; membranous nephropathy, and proteinuria in the nephrotic range received therapy with interferon-alpha in standard doses. Results. The prevalence of anti-HCV positivity was 13% (38/284). The frequency of anti-HCV positivity ranged between 0 and 100% in the different types of renal diseases, the difference was statistically significant (P = 0.0001). The anti-HCV rate was significantly higher in patients with cryoglobulinaemic membrano-proliferative and mesangioproliferative GN than among the other individuals (14/14 (100%) vs 24/270 (9%), P = 0.0002). Our multivariate analysis by logistic regression model showed that age (P = 0.0017) and type of renal diseases (P = 0.0007) were independently and significantly associated with anti-HCV antibody. At the completion of treatment with interferon-alpha, 67% (2/3) of patients with membranous nephropathy had lowering of hepatic enzyme levels into the normal range whereas 100% (3/3) of these did not show significant reduction of proteinuria. Conclusions. We observed strong association between HCV infection and cryoglobulinaemic GN. Age and type of renal disease were important independent predictors of anti-HCV positivity in our cohort of patients. Three anti-HCV-positive patients with membranous nephropathy did not show significant remission of nephrotic proteinuria after treatment with interferon-alpha. Our data do not appear to support an association between HCV and non-cryoglobulinaemic GN. Further epidemiological surveys, experimental studies and clinical trials are warranted to fully elucidate the role of HCV in non-cryoglobulinaemic GN. Keywords: HCV; cryoglobulinaemic and non-cryoglobulinaemic glomerulonephritis; interferon therapy
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
L. S. Dalrymple, T. Koepsell, J. Sampson, T. Louie, J. A. Dominitz, B. Young, and B. Kestenbaum
Hepatitis C Virus Infection and the Prevalence of Renal Insufficiency
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 715 - 721.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. I. Tsui, E. Vittinghoff, M. G. Shlipak, D. Bertenthal, J. Inadomi, R. A. Rodriguez, and A. M. O'Hare
Association of Hepatitis C Seropositivity With Increased Risk for Developing End-stage Renal Disease
Arch Intern Med, June 25, 2007; 167(12): 1271 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. I. Tsui, E. Vittinghoff, M. G. Shlipak, and A. M. O'Hare
Relationship between Hepatitis C and Chronic Kidney Disease: Results from the Third National Health and Nutrition Examination Survey
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1168 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
I. Nussenzveig, T. De Brito, C. R. W. Carneiro, and A. M. G. Silva
Human Schistosoma mansoni-associated glomerulopathy in Brazil
Nephrol. Dial. Transplant., January 1, 2002; 17(1): 4 - 7.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Dussol, V. Moal, L. Daniel, C. Pain, and Y. Berland
Spontaneous remission of HCV-induced cryoglobulinaemic glomerulonephritis
Nephrol. Dial. Transplant., January 1, 2001; 16(1): 156 - 159.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.